| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.LUNGCAN.2008.02.013 |
| P8608 | Fatcat ID | release_2iy6czavy5fvpnkgszisheg7oa |
| P698 | PubMed publication ID | 18395929 |
| P50 | author | Hiroyuki Yanai | Q61161145 |
| P2093 | author name string | Hiromasa Yamamoto | |
| Shinichi Toyooka | |||
| Nobukazu Fujimoto | |||
| Hiroshi Date | |||
| Yoshifumi Sano | |||
| Junichi Soh | |||
| Takumi Kishimoto | |||
| Kouichi Ichimura | |||
| Naruyuki Kobayashi | |||
| Shuji Ichihara | |||
| Kentaro Kimura | |||
| P433 | issue | 1 | |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 120-125 | |
| P577 | publication date | 2008-04-18 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma. | |
| P478 | volume | 62 |
| Q54335306 | Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma. |
| Q38888134 | Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients. |
| Q47912434 | Advances in systemic therapy for malignant mesothelioma: future perspectives |
| Q39632612 | Alterations of p14 ARF , p15 INK4b , and p16 INK4a Genes in Primary Laryngeal Squamous Cell Carcinoma |
| Q36642812 | CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma |
| Q43191497 | CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival |
| Q64288080 | CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure |
| Q47181318 | Changes in DNA methylation induced by multi-walled carbon nanotube exposure in the workplace. |
| Q50050310 | Clinical and biologic prognostic factors in malignant pleural mesothelioma. |
| Q28395184 | DNA copy number gains in malignant pleural mesothelioma |
| Q54463086 | Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. |
| Q36286635 | Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients |
| Q60954580 | Establishment and characterization of CRISPR/Cas9-mediated NF2 human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma |
| Q36503271 | Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma. |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q37573248 | Immunohistochemical expression of p16 in Carcinoma Ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types). |
| Q49232092 | Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma. |
| Q28253632 | Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer |
| Q38164703 | Role of cyclooxygenase-2 in gastric cancer development and progression |
| Q38950690 | The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma |
| Q58580685 | miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma |
Search more.